Cancer researchers hit a bullseye with new drug target for Ewing sarcoma

Researchers have found that Ewing sarcoma cells die if an enzyme called CDK12 is knocked out genetically or chemically inhibited. What’s more, when a CDK12 inhibitor is combined with another drug, called a PARP inhibitor, the two drugs double down to deliver a lethal punch to Ewing sarcoma cells.

🕐 Top News in the Last Hour By Importance Score

#	Title	📊 i-Score
1	Le Pen calls embezzlement conviction a 'witch hunt'	🔴 75 / 100
2	Piers Morgan leads outrage after two transgender players contest final of women's pool competition – as Sharron Davies labels event 'grossly wrong in every way'	🔴 72 / 100
3	We live in some of Britain's picture postcard beauty spots – but coachloads of selfie-loving tourists are dividing our idyllic villages	🔴 72 / 100
4	Marvel Rivals Fans Are Having Trouble Telling All Of The Blondes Apart	🔴 72 / 100
5	Sahel alliance recalls ambassadors from Algeria after the downing of a Malian drone	🔴 72 / 100
6	New York is plotting another tax hike to keep feeding health care special interests	🔴 72 / 100
7	One in four Britons victim of ticket scams for in-demand events, says Nationwide	🔴 65 / 100
8	DOGE plans now reportedly include an IRS ‘hackathon’	🔴 65 / 100
9	How to Use Your Car as a Wi-Fi Hotspot	🔵 55 / 100
10	Florida principal caught using Walmart 'foam plate hack' put on disciplinary leave: 'My friends told me to'	🔵 52 / 100

View More Top News ➡️